Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 502

1.

Neoadjuvant Chemotherapy Enhances Local Postoperative Histopathological Tumour Stage in Borderline Resectable Pancreatic Cancer - A Matched-Pair Analysis.

Timmermann L, Rosumeck N, Klein F, Pratschke J, Pelzer U, Bahra M, Malinka T.

Anticancer Res. 2019 Oct;39(10):5781-5787. doi: 10.21873/anticanres.13781.

PMID:
31570482
2.

Dynamic liver function is an independent predictor of recurrence-free survival after curative liver resection for HCC - A retrospective cohort study.

Blüthner E, Bednarsch J, Malinowski M, Binder P, Pratschke J, Stockmann M, Kaffarnik M.

Int J Surg. 2019 Sep 5;71:56-65. doi: 10.1016/j.ijsu.2019.08.033. [Epub ahead of print]

PMID:
31494333
3.

Postoperative acute necrotizing pancreatitis of the pancreatic remnant (POANP): a new definition of severe pancreatitis following pancreaticoduodenectomy.

Globke B, Timmermann L, Klein F, Fehrenbach U, Pratschke J, Bahra M, Malinka T.

HPB (Oxford). 2019 Aug 17. pii: S1365-182X(19)30635-5. doi: 10.1016/j.hpb.2019.07.016. [Epub ahead of print]

PMID:
31431414
4.

Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial.

Garlipp B, Gibbs P, Van Hazel GA, Jeyarajah R, Martin RCG, Bruns CJ, Lang H, Manas DM, Ettorre GM, Pardo F, Donckier V, Benckert C, van Gulik TM, Goéré D, Schoen M, Pratschke J, Bechstein WO, de la Cuesta AM, Adeyemi S, Ricke J, Seidensticker M.

Br J Surg. 2019 Aug 19. doi: 10.1002/bjs.11283. [Epub ahead of print]

PMID:
31424576
5.

Development of a Rat Liver Machine Perfusion System for Normothermic and Subnormothermic Conditions.

Nösser M, Gassner JMGV, Moosburner S, Wyrwal D, Claussen F, Hillebrandt KH, Horner R, Tang P, Reutzel-Selke A, Polenz D, Arsenic R, Pratschke J, Sauer IM, Raschzok N.

Tissue Eng Part A. 2019 Sep 18. doi: 10.1089/ten.TEA.2019.0152. [Epub ahead of print]

PMID:
31364485
6.

[Elective treatment of inguinal hernia in university surgery-an economic challenge].

Raakow J, Aydin M, Kilian M, Köhler A, Werner S, Pratschke J, Fikatas P.

Chirurg. 2019 Jul 29. doi: 10.1007/s00104-019-1008-z. [Epub ahead of print] German.

PMID:
31359111
7.

Improved Survival in Liver Transplant Patients Receiving Prolonged-release Tacrolimus-based Immunosuppression in the European Liver Transplant Registry (ELTR): An Extension Study.

Adam R, Karam V, Cailliez V, Trunečka P, Samuel D, Tisone G, Němec P, Soubrane O, Schneeberger S, Gridelli B, Bechstein WO, Risaliti A, Line PD, Vivarelli M, Rossi M, Pirenne J, Klempnauer JL, Rummo A, Di Benedetto F, Zieniewicz K, Troisi R, Paul A, Vali T, Kollmar O, Boudjema K, Hoti E, Colledan M, Pratschke J, Lang H, Popescu I, Ericzon BG, Strupas K, De Simone P, Kochs E, Heyd B, Gugenheim J, Pinna AD, Bennet W, Kazimi M, Bachellier P, Wigmore SJ, Rasmussen A, Clavien PA, Hidalgo E, O'Grady JG, Zamboni F, Kilic M, Duvoux C; all contributing centers (www.eltr.org) and the European Liver and Intestine Transplant Association (ELITA).

Transplantation. 2019 Sep;103(9):1844-1862. doi: 10.1097/TP.0000000000002700.

PMID:
31343568
8.

Gd-EOB-DTPA-enhanced MRI T1 relaxometry as an imaging-based liver function test compared with 13C-methacetin breath test.

Theilig D, Tsereteli A, Elkilany A, Raabe P, Lüdemann L, Malinowski M, Stockmann M, Pratschke J, Hamm B, Denecke T, Geisel D.

Acta Radiol. 2019 Jul 19:284185119861314. doi: 10.1177/0284185119861314. [Epub ahead of print] No abstract available.

PMID:
31324131
9.

Influence of the body mass index on postoperative outcome and long-term survival after pancreatic resections in patients with underlying malignancy.

Seika P, Klein F, Pelzer U, Pratschke J, Bahra M, Malinka T.

Hepatobiliary Surg Nutr. 2019 Jun;8(3):201-210. doi: 10.21037/hbsn.2019.02.05.

10.

Safety and Efficiency of Single-Incision Laparoscopic Cholecystectomy in Obese Patients: A Case-Matched Comparative Analysis.

Raakow J, Klein D, Barutcu AG, Biebl M, Pratschke J, Raakow R.

J Laparoendosc Adv Surg Tech A. 2019 Aug;29(8):1005-1010. doi: 10.1089/lap.2018.0728. Epub 2019 Jun 24.

PMID:
31233349
11.

Teburu-Open source 3D printable bioreactor for tissue slices as dynamic three-dimensional cell culture models.

Daneshgar A, Tang P, Remde C, Lommel M, Moosburner S, Kertzscher U, Klein O, Weinhart M, Pratschke J, Sauer IM, Hillebrandt KH.

Artif Organs. 2019 Jun 18. doi: 10.1111/aor.13518. [Epub ahead of print]

PMID:
31211867
12.

Analysis of outcomes and predictors of long-term survival following resection for retroperitoneal sarcoma.

Malinka T, Nebrig M, Klein F, Pratschke J, Bahra M, Andreou A.

BMC Surg. 2019 Jun 10;19(1):61. doi: 10.1186/s12893-019-0521-9.

13.

Immunologic cellular characteristics of the tumour microenvironment of hepatocellular carcinoma drive patient outcomes.

Atanasov G, Dino K, Schierle K, Dietel C, Aust G, Pratschke J, Seehofer D, Schmelzle M, Hau HM.

World J Surg Oncol. 2019 Jun 6;17(1):97. doi: 10.1186/s12957-019-1635-3.

14.

Strategies based on organ decellularization and recellularization.

Hillebrandt KH, Everwien H, Haep N, Keshi E, Pratschke J, Sauer IM.

Transpl Int. 2019 Jun;32(6):571-585. doi: 10.1111/tri.13462. Review.

PMID:
31099920
15.

Effects of expanded allocation programmes and organ and recipient quality metrics on transplant-related costs in kidney transplantation - an institutional analysis.

Dziodzio T, Jara M, Hardt J, Weiss S, Ritschl PV, Denecke C, Biebl M, Gerlach U, Reinke P, Pratschke J, Öllinger R.

Transpl Int. 2019 Oct;32(10):1074-1084. doi: 10.1111/tri.13463. Epub 2019 Jun 6.

PMID:
31099091
16.

Expression Analysis of Fibronectin Type III Domain-Containing (FNDC) Genes in Inflammatory Bowel Disease and Colorectal Cancer.

Wuensch T, Wizenty J, Quint J, Spitz W, Bosma M, Becker O, Adler A, Veltzke-Schlieker W, Stockmann M, Weiss S, Biebl M, Pratschke J, Aigner F.

Gastroenterol Res Pract. 2019 Apr 9;2019:3784172. doi: 10.1155/2019/3784172. eCollection 2019.

17.

Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.

Haldar D, Kern B, Hodson J, Armstrong MJ, Adam R, Berlakovich G, Fritz J, Feurstein B, Popp W, Karam V, Muiesan P, O'Grady J, Jamieson N, Wigmore SJ, Pirenne J, Malek-Hosseini SA, Hidalgo E, Tokat Y, Paul A, Pratschke J, Bartels M, Trunecka P, Settmacher U, Pinzani M, Duvoux C, Newsome PN, Schneeberger S; European Liver and Intestine Transplant Association (ELITA).

J Hepatol. 2019 Aug;71(2):313-322. doi: 10.1016/j.jhep.2019.04.011. Epub 2019 May 7.

18.

The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis.

Rau B, Brandl A, Thuss-Patience P, Bergner F, Raue W, Arnold A, Horst D, Pratschke J, Biebl M.

Gastric Cancer. 2019 May 7. doi: 10.1007/s10120-019-00969-1. [Epub ahead of print]

PMID:
31065877
19.

Laparoscopic versus open hemihepatectomy-a cost analysis after propensity score matching.

Wabitsch S, Kästner A, Haber PK, Feldbrügge L, Winklmann T, Werner S, Pratschke J, Schmelzle M.

Langenbecks Arch Surg. 2019 Jun;404(4):469-475. doi: 10.1007/s00423-019-01790-1. Epub 2019 May 7.

PMID:
31065781
20.

Macrosteatosis is a huge problem in liver transplantation-however, not the only one we face.

Moosburner S, Sauer IM, Gassner JMGV, Schleicher C, Bösebeck D, Rahmel A, Pratschke J, Raschzok N.

Am J Transplant. 2019 Sep;19(9):2661-2662. doi: 10.1111/ajt.15418. Epub 2019 May 28. No abstract available.

PMID:
31062467

Supplemental Content

Loading ...
Support Center